PDG58 Incremental Effectiveness of Inotuzumab Ozogamicin for the Treatment of Relapsed or Refractory CD22-Positive B Cell Precursor Acute Lymphoblastic Leukaemia in Portugal
Autor: | Silva Miguel, L., Paquete, A.T., Inês, M., Borges, M. |
---|---|
Zdroj: | In Value in Health December 2020 23 Supplement 2:S528-S528 |
Databáze: | ScienceDirect |
Externí odkaz: |